Email Newsletters

Marlborough

🔒Movers & Shakers for Sept. 27, 2021

People are on the move at Adcare Hospital, ERA Key Spencer, Savers Bank, and more.

🔒Mini-cluster: Worcester is trying to carve out its own niche in biotech

Located adjacent to the Polar Park baseball stadium in Worcester, the planned Left Field Building is a $16-million symbol of the ambitious plans in the city for the life sciences as a catalyst for its ever-evolving development efforts.

🔒Revival: The independent bookstore industry is growing with a loyal customer base wanting to shop local

As people around the U.S. turned inward over the last year and a half, consumers appear to have found a respite from the onslaught of technology dependence: reading.

Marlborough land near industrial developments sells for $2.1M

A 24-acre parcel of land at 149 Hayes Memorial Drive on the Marlborough-Northborough border sold to Toronto realty company Oxford Properties Group for $2.1 million, according to the Middlesex South Registry of Deeds.
ADVERTISEMENT

Hologic’s global study reveals gaps in women’s healthcare

Hologic, a Marlborough-based medical technology company focused on women’s health, released findings from its first Hologic Global Women’s Health Index, according to a Tuesday press release.

Boston Scientific cancer treatment shown to be effective in clinical trial

Marlborough medical device manufacturer Boston Scientific Corp. announced Monday a clinical trial for its TheraSphere cancer treatment successfully met both of its primary endpoints.

Akoya Biosciences welcomes GeneCentric founder to its board

Akoya Biosciences, a Marlborough bioscience company, has appointed Dr. Myla Lai-Goldman, who has worked extensively in diagnostics and is the chair and co-founder of GeneCentric Therapeutics Inc. of North Carolina, to its board of directors, according to a Wednesday announcement.

Boston Scientific to buy California anti-blood clot firm for up to $400M

Marlborough-based medical device maker Boston Scientific announced on Tuesday it has entered an agreement to acquire California anti-blood clot technology maker Devoro Medical, Inc. of California.
ADVERTISEMENT

Jam out to the WBJ 40 Under Forty playlist

Songs include "Vogue" by Madonna, "Sweet Jane" by The Velvet Underground, "Return of the Mack" by Mark Morrison, "Whatta Man" by Salt-N-Pepa, and "All I Do Is Win" by DJ Khaled.

Immunovia signs cancer license agreement with South Korean biotech

Marlborough diagnostic company Immunovia, Inc. announced on Monday it has acquired a global license from the South Korean company JW BioScience’s intellectual property portfolio, granting Immunovia global commercial rights for two biomarkers.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA